Tempus AI Falls 15% on Weak Q4 but EBITDA View Strong: Buy the Dip? [Yahoo! Finance]
Tempus AI, Inc. - Class A (TEM)
Company Research
Source: Yahoo! Finance
The stock had been on a strong upward trend but its weaker-than-anticipated fourth-quarter 2024 results, released on Feb. 24, resulted in a sharp decline, with shares dropping more than 15% the next day. Concerns over revenue timing shifts and market conditions resulted in the downturn. Nevertheless, with an increased 2025 revenue forecast of $1.24 billion and expectations of positive adjusted EBITDA, Tempus AI still remains positioned for long-term growth. Year to date, the stock has rallied 75%, outperforming the 21.6% rise of the Medical Info Systems industry and the Medical sector's 6.4% increase. In the meantime, the benchmark S&P 500 edged up 1.5%. The company has also outperformed other players in the health infotech field, like iRhythm Technologies IRTC and SOPHiA GENETICS SOPH, which improved 26.3% and 21.8%, respectively, during the said period. YTD Price Comparison Zacks Investment Research Image Source: Zacks Investment Research Key Q4 and 2024 Takeaways In t
Show less
Read more
Impact Snapshot
Event Time:
TEM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TEM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TEM alerts
High impacting Tempus AI, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
TEM
News
- Tempus Announces Ten Abstracts Accepted for Presentation at the 2025 San Antonio Breast Cancer SymposiumBusiness Wire
- Tempus AI, Inc. (TEM): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Tempus AI (NASDAQ:TEM) was given a new $85.00 price target on by analysts at Morgan Stanley.MarketBeat
- Cathie Wood's Health Tech Bet: Why Analysts See Long-Term Upside in Tempus AI (TEM) [Yahoo! Finance]Yahoo! Finance
- Tempus AI (NASDAQ:TEM) had its "buy" rating reaffirmed by analysts at BTIG Research.MarketBeat
TEM
Earnings
- 11/4/25 - Beat
TEM
Sec Filings
- 12/12/25 - Form 4
- 12/11/25 - Form 144
- 12/9/25 - Form 4
- TEM's page on the SEC website